http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 13 May 2026 15:38:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html si-local-file:///var/storage/secattach/20260513/26485481.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html Wed, 13 May 2026 15:38:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html si-local-file:///var/storage/secattach/20260513/26485481.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html Wed, 13 May 2026 15:38:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html si-local-file:///var/storage/secattach/20260513/26485481.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BIO-RAD+LABORATORIES%2C+++++For%3A+May+11++Filed+by%3A+ENGELHARDT+EVA+ANETTE/26485481.html Wed, 13 May 2026 15:38:00 -0400 BIO BIO.B O.00005917 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Press+Releases/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: </p><p> <b>2026 RBC Capital Markets Global Healthcare Conference <br /></b>Format: Fireside chat and one-on-one investor meetings <br />Participants: Roop K. Lakkaraju, Chief Financial Officer <br />Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Frbc%2Fbio-rad-laboratories-inc-may-2026&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=webcast&amp;index=1&amp;md5=9dd8f8a2a3557fc1fa53a9d177e792ac" shape="rect">webcast</a> and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bio-rad.com%2Foverview%2Fdefault.aspx&amp;esheet=54531829&amp;newsitemid=20260508350759&amp;lan=en-US&amp;anchor=bio-rad.com&amp;index=2&amp;md5=7619b8d32c5e2018d23e919c8c5db8be" http://www.streetinsider.com/Business+Wire/Bio-Rad+to+Participate+in+Upcoming+Investor+Conferences/26458485.html Fri, 08 May 2026 09:00:00 -0400 A.29655321 BIO BIO.B O.00005917 O.14972255 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Press+Releases/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Business+Wire/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Business+Wire/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Business+Wire/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Business+Wire/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Business+Wire/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Business+Wire/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Business+Wire/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Business+Wire/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637 http://www.streetinsider.com/Business+Wire/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html <p> HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. </p><p> Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the Middle East, reported sales grew 1.1% year-over-year. Against this backdrop, we generated strong operating cash flow, $78 million in free cash flow, and repurchased approximately 176 thousand shares, highlighting the quality and http://www.streetinsider.com/Business+Wire/Bio-Rad+Reports+First-Quarter+2026+Financial+Results/26408058.html Thu, 30 Apr 2026 16:15:00 -0400 A.29655321 A.50210587 BIO BIO.B O.00005917 O.14972255 O.23727637